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ABSTRACT
Purpose: Thermal intervention is a potent sensitizer of cells to chemo- and radiotherapy in cancer
treatment. Glioblastoma multiforme (GBM) is a potential clinical target, given the cancer’s aggressive
nature and resistance to current treatment options. The annular phased array (APA) technique employ-
ing electromagnetic waves in the radiofrequency (RF) range allows for localized temperature increase
in deep seated target volumes (TVs). Reports on clinical applications of the APA technique in the brain
are still missing. Ultrahigh field magnetic resonance (MR) employs higher frequencies than conven-
tional MR and has potential to provide focal temperature manipulation, high resolution imaging and
noninvasive temperature monitoring using an integrated RF applicator (ThermalMR). This work exam-
ines the applicability of RF applicator concepts for ThermalMR of brain tumors at 297MHz (7.0 Tesla).
Methods: Electromagnetic field (EMF) simulations are performed for clinically realistic data based on
GBM patients. Two algorithms are used for specific RF energy absorption rate based thermal interven-
tion planning for small and large TVs in the brain, aiming at maximum RF power deposition or RF
power uniformity in the TV for 10RF applicator designs.
Results: For both TVs, the power optimization outperformed the uniformity optimization. The best
results for the small TV are obtained for the 16 element interleaved RF applicator using an elliptical
antenna arrangement with water bolus. The two row elliptical RF applicator yielded the best result for
the large TV.
Discussion: This work investigates the capacity of ThermalMR to achieve targeted thermal interven-
tions in model systems resembling human brain tissue and brain tumors.
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Introduction
Glioblastoma multiforme (GBM) is the most frequent and
aggressive malignant brain tumor with the least chance of
long-term survival, in spite of multimodal therapeutic
approaches that include surgery, radiotherapy and chemo-
therapy [1]. Local thermal therapy is a potent sensitizer of
several cancer cell types to chemo- and radiotherapy [2–5]
and significantly improves survival [5]. In case of GBM, add-
ing thermal therapy to standard treatment could improve
prognosis [1,5]. A randomized trial showed the principal
effectiveness of brachytherapy and adjunct interstitial hyper-
thermia, prolonging median survival [6]. The disproportional
effort and burden of this approach has prevented broader
clinical application and constitutes the rationale for a
noninvasive approach for thermal therapy. GBM treatment
could also benefit from manipulation of the blood brain bar-
rier enhancing its permeability and thus targeted drug deliv-
ery to the tumor location [7–9].
Limitations of energy delivery restrict the use of conven-
tional thermal therapy approaches in the brain. Capacitive
approaches were already clinically applied [10]. Their ability
to achieve high SAR in deep tissue and to focus to a well-
defined target region is limited [11,12]. MR-guided focused
ultrasound (MRgFUS) permits noninvasive thermo-ablation of
deep seated brain tumors [13]. This approach provides
unmatched focal quality [14], although excessive treatment
duration often results in incomplete treatment of the clinical
target volumes (TVs) [15].
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Radiative annular phased arrays (APAs) of antennae oper-
ating in the radiofrequency (RF) range enable localized tem-
perature intervention in deep-seated TVs in the pelvis and
abdomen [2], where the commonly applied frequencies of
f¼ 70–130MHz result in wavelengths k between 50 and
25 cm and thus the minimum size of the heated volume is
as large as about 10 cm (about one-third of the wavelength)
[16,17]. Employing a higher frequency of f¼ 434MHz affords
smaller TVs in the treatment of head and neck cancers [18].
Numerical simulations demonstrated that moving to frequen-
cies of up to 1GHz and a potential combination thereof ena-
bles better control over the distribution of the delivered RF
energy to the target [19–22].
A plethora of reports highlights the need and growing
clinical interest for RF-based thermal therapy in the brain
[19,21–24]. However, reports on clinical applications of the
APA technology are still missing due to the lack of a nonin-
vasive method to manipulate brain tissue temperature while
concomitantly characterizing its outcome in vivo, which is a
pivotal prerequisite when targeting the brain. Temperature
probes provide accurate readings but are constrained to
point-wise measurements. Their placement is invasive and
might not be feasible depending on the size and location of
the TV.
Magnetic resonance imaging (MRI) provides anatomic ref-
erence, facilitates functional contrast and supports noninva-
sive temperature mapping and is therefore of great interest
but has still limited accessibility for clinical users [12,25].
Current implementations use separate RF antenna systems
for RF hyperthermia and MRI [12]. For the latter, the MR
scanner’s body RF coil is employed. This approach constrains
MR thermometry (MRTh) to a low signal-to-noise ratio, which
limits the spatial resolution and accuracy of temperature
maps [26,27]. Further constraints apply to the design of the
RF heating device: the RF antenna system for hyperthermia
must be efficiently decoupled from the MR imaging system
to avoid RF induced artifacts in the MRTh data as well as
perturbations in the RF transmission during treatment [2,28].
Thermal magnetic resonance (ThermalMR) has the unique
potential to circumvent these limitations by providing tem-
perature intervention, proton (1H) MRI for anatomic and
functional imaging and temperature mapping (MRTh) in an
integrated RF applicator. Ultrahigh field MR (UHF-MR) at
B07.0 Tesla (f 297MHz) enables high focusing of RF fields,
provides thermal dose delivery for hyperthermia in relatively
large tumor areas and affords enhanced spatial resolution for
MRI and MRTh [20,23,27,29,30]. By enabling treatment and
therapy monitoring on the same RF antenna hardware, the
risk of interferences between treatment and therapy monitor-
ing is eliminated.
Recognizing the opportunities of adding a thermal inter-
vention dimension to a UHF-MR device, this work examines
RF applicator concepts tailored for simultaneous RF heating
and UHF-MR to combine diagnostic MRI, RF hyperthermia
treatment and real-time therapy control with MRTh. En route
to RF-induced hyperthermia treatment of glioblastoma in the
human brain, this work focuses on electromagnetic field
(EMF) simulations that incorporate models based on clinical
data obtained from GBM patients and presents two algo-
rithms for specific RF energy absorption rate (SAR)-based
hyperthermia treatment planning (HTP) for small and large
TVs in the brain.
Materials and methods
Radiofrequency antenna array concepts
Ten RF arrays comprising 8, 16 or 32 antenna building blocks
(Figure 1) were modeled. Each building block consists of a
bow tie dipole antenna [23,31] submerged in a high permit-
tivity medium enclosed in a polymethylmethacrylate (PMMA)
box (wall thickness ¼ 3mm).
Design 1 (Figure 1(a)) provides a reference [22] and con-
sists of eight building blocks (size: (35 70 150) mm3) posi-
tioned azimuthally (inner diameter ¼ 24 cm) around the
human head. D2O (er  80) was used as high permittivity
medium for antenna size reduction [32].
For Designs 2–6, the number of transmit channels was
increased to 16 versus the reference design, which poten-
tially improves in-plane RF steering capabilities and the ratio
between deep seated and superficial SAR [20]. In order to
allow for the increased number of channels, while keeping
the overall dimensions of the applicator comparable, a
higher permittivity dielectric (er  200) was employed, which
reduced the building block size to (40 40 80) mm3.
Design 2 (Figure 1(b)) comprises 16 resonators arranged in
a circular array in plane.
Starting with Design 3 (Figure 1(c)), an interleaved
arrangement of building blocks along the head-feet-direction
(z-direction) was introduced in order to sharpen and move
the focus along the third dimension. Designs 3 and 4 use an
offset of 32mm between adjacent building blocks, which
represents half the length of the dipole.
Design 4 (Figure 1(d)) is an elliptical variant of Design 3 to
reduce the proximity of the elements to the front and the
back of the head and to mitigate formation of local SAR
maxima. The eccentricity of the ellipse (a1¼220mm,
a2¼260mm) was chosen to reproduce the circumference of
the circular arrays.
To enhance brain coverage, the offset of the building
blocks in head-feet-direction was set to the length of the
building block (89mm) for Designs 5–8, forming two separate
rows.
Design 5 (Figure 1(e)) is a circular two row arrangement
with eight elements each.
Design 6 (Figure 1(f)) is an elliptical variant of Design 5
with improved longitudinal coverage over Design 4.
For Designs 7 and 8, 32 building block elements were
used. The circular Design 7 (Figure 1(g)) consists of two rows,
each equipped with 16 elements.
Design 8 (Figure 1(h)) is an elliptical variant of Design 7
with an enhanced conformity to the shape of the head. Note
that for Designs 1–8 an air gap is assumed between anten-
nae and head.
Building block arrangements in Designs 9 and 10
(Figure 1(i,j)) are identical to Designs 3 and 4, with the
exception that a cylindrical water bolus (h¼ 120mm) was
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introduced to fill the air gap between the RF arrays and the
human head for better coupling of the RF waves to the
body [33].
A prerequisite of MRI is the perpendicularity of the mag-
netic transmission field (B1
þ) and the static magnetic field of
the MR system (B0). Due to the radiation pattern of bow tie
dipole antennae, the building blocks need to be arranged
with their long axis parallel to the head-feet-direction. For
Designs 2–10, copper shields were introduced between the
RF building blocks to reduce nearest neighbor coupling. The
position of each array was chosen so that the brain is cen-
tered within the x–y-plane (left–right, anterior–posterior) of
the array and the TV for HTP is centered in the z-direction
(superior–inferior). The combination of a voxel model with a
specific RF applicator design will further be referred to as
‘configuration’.
All material parameters used for the EMF simulations are
provided in Table 1.
Electromagnetic field simulations
EMF simulations were performed using Sim4Life V3.4
(ZurichMedTech, Zurich, Switzerland), with a broadband exci-
tation at 297 ± 50MHz and a simulation time of t¼ 120 ns.
The resolution was limited to a maximum step size of 3mm
within the skull and 5mm within the lower region of the
voxel model. A much finer resolution of down to 0.5mm was
applied to resolve the triangular shape of the bow
tie dipoles.
Human voxel models
To address patients’ individuality, EMF simulations were per-
formed for two voxel models of the human head:
1. Human voxel model ‘Duke’ of the virtual family [34]
(IT’IS Foundation, Z€urich, Switzerland) was modified to
include an intracranial sphere (d¼ 4 cm, rTumor¼1.15S/m,
er,Tumor¼66.5 [34]) mimicking a small (<k/2) tumor in the
right parietal region of the brain with a TV of
Vtarget¼33.5ml. To ensure a closed layer of cerebrospinal
fluid (CSF) to account for a potential RF shielding effect
[37], the dura of the voxel model was assigned electro-
magnetic material properties of CSF (r¼ 2.22S/m) [35].
This model will be further referred to as ‘small
tumor model’.
2. To mimic the clinical scenario, a realistic voxel model
representing a patient with GBM encompassing a large
TV (>k/2, Vtarget¼500ml) was generated from a com-
puted tomography (CT) scan of a patient [39]. The
resulting voxel data exhibits the same resolution as the
planning CT and distinguishes up to 20 labeled tissues,
which were assigned EM material properties of tissue
[35]. A closed layer of external CSF was generated by
upscaling the size of the brain by 5% while maintaining
its shape and overwriting existing voxels assigned to
muscle and skull. Assigning EM properties of CSF to the
created envelope resulted in a closed layer with a
Figure 1. Overview over all 10 RF applicator designs investigated in this work.
In the center column, cross-sectional view of the RF arrays depicts the arrange-
ment of the building blocks around the head and details about their position
with respect to each other. The rightmost column shows the designs and their
positioning for the small tumor model.
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thickness of 2–3mm depending on the local mesh. This
model will be further referred to as ‘large tumor model’.
Data processing
A circuit co-simulation was performed in MATLAB (MATLAB
2016b, The MathWorks, Natick, MA), optimizing the values of
two lossy capacitances (equivalent series resistance ¼ 0.15 X,
equivalent series inductance ¼ 1 nF) for channel-wise match-
ing and tuning [40], minimizing the trace of the scattering
matrix. The multi-channel point-SAR distributions were scaled
based on the resulting scattering matrix and rebinned [41] to
an isotropic grid of 3mm. Our approach of thermal MR
includes HTP and MR imaging. For the latter, guidelines
ensuring patient safety rely on SAR averaging over cubes
covering 10 g of tissue [42]. To be in compliance with these
guidelines and to be consistent throughout our calculations,
SAR10g averaging [43] was also employed for the HTP. A
good correlation of this averaging mass with temperature
rise has been reported for the applied frequency range
[43,44], in the head [45,46] and in hyperthermia treatment of
a human subject [47]. This IEEE guideline foresees that aver-
aging volumes comprising more than 10% air shall be
assigned values from averaging cubes reaching into body
instead of outwards. Since this does not generate new
insights on the search for maximum SAR10g values but rather
assigns values to two locations, the locations resulting in a
volume with a fill rate of less than 90% were discarded to
decrease the data volume. Virtual observation points (VOPs)
were calculated to accelerate the optimization [48,49], yield-
ing a VOP-based result. The overestimation was chosen for
each configuration so that the number of VOPs was
500± 10%. After optimization, the non-compressed field data
were combined with the obtained phase and amplitude set-
ting (full result). Values for local (SAR10g,max(healthy)) and glo-
bal (PHead) exposure were compared with and without the
use of VOPs and the amplitude of the excitation vectors was
scaled to match the full results to the VOP-based results,
thus partially removing the intrinsic overestimation by the
VOP approach. A general overview of the workflow is given
in Figure 2(a).
Hyperthermia treatment planning
For the HTP, two optimization algorithms were developed,
evaluated and compared for all RF coil array designs and for
both tumor models. The goal of the optimization is to find
excitation vectors defining the phase and amplitude setting
for each channel. The resulting SAR pattern of the interfering
incident electric fields causes the TV to heat up while the
healthy tissue is spared of such exposure. We consider the
scenario where multiple excitation settings can be played
out consecutively so that their cumulative exposure consti-
tutes the overall SAR pattern. The number of settings can be
as high as the number of channels in the RF array. To sup-
press all solutions that contribute with less than 0.1% to the
total delivered RF power, a threshold was introduced.
To describe the problem, we describe the power as the
average power delivered in each of the m excitations, as pre-
viously described for a single excitation in [50]:
P ¼ 1
m
Xm
j¼1
xHj Qxj, (1)
where xj are the individual excitation vectors and Q is the
positive (semi)definite (psd) power correlation matrix of the
Table 1. Materials and dielectric parameters used for electromagnetic field simulations.
Model Component Material r (S/m) Er q (g/cm3)
Small tumor model Tumor growth Tumor 1.15 66.5 1025.5
Duke All tissues IT’IS database
Closed layer of CSF Dura ! CSF 2.22 72.8 1007
Large tumor model Tumor growth Tumor 1.15 66.5 1025.5
Brain 40% WM þ 60% GM 0.52 50.3 1043
Brainstem 40% WM þ 60% GM 0.52 50.3 1043
Tissue
Fat 0.07 11.7 911
Muscle 0.77 58.2 1090.4
Skull Bone 0.08 13.5 1908
Eye Vitreous humor 1.52 69.0 1004.5
Optical nerve
Nerve
0.42 37.0 1075
Chiasm
Spinal cord
Vessels Blood 1.32 65.7 1049.8
Cavities Air 0 1 1
Pituitary gland
Hypothalamus
0.85 62.5 1053
Hypothalamus
Heavy water resonator (design 1) Dielectric resonator Heavy water (D2O) 0.02 81 1000
Casing Plexiglass (PMMA) 0.025 3.6 1180
Antenna substrate FR-4 0.025 4.3 1800
Bow tie antenna PEC
High permittivity resonator
(designs 2–10)
Dielectric resonator Ceramic slurry 0.2 200 6020
Casing Plexiglass (PMMA) 0.025 3.6 1180
Antenna substrate FR-4 0.025 4.3 1800
Bow tie antenna PEC
Water bolus (designs 9þ 10) Deionized water 0.016 81 1000
WM: white matter; GM: gray matter.
Parameters sources: tumor tissue [34]; body tissues [35]; D2O, deionized water, ceramic slurry: bench measurement based on an open-end coaxial probe setup
[36,37]; PMMA, FR-4: material datasheets.
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tumor [51]. The dimension N of the vector corresponds to
the number of channels of the system. With a local SAR
matrix Si for each healthy voxel i, local SAR for these excita-
tions equates to
SARi ¼ 1m
Xm
j¼1
xHj Sixj: (2)
A similar matrix can be constructed to calculate global
SAR. Using appropriate compression methods, the SAR matri-
ces can be replaced by a much smaller number of VOPs [48].
Both expressions for power deposition and local SAR are
sums of quadratic forms, which can be rewritten using the
trace operator to yield
Figure 2. (a) Schematic presentation of the workflow from the diagnostic MRI of the patient to the SAR10g distribution as the hyperthermia treatment planning.
(b) Details of the simulation and optimization process from the tumor models to the metrics to be evaluated to assess the RF array for hyperthermia treatment
planning and magnetic resonance imaging performance.
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tr
1
m
Xm
j¼1
xHj Qxj
 !
¼ 1
m
Xm
j¼1
tr xHj Qxj
 
¼ 1
m
Xm
j¼1
tr QX jð Þ ¼ 1mtr Q
Xm
j¼1
X j
 !
¼ 1
m
tr QYð Þ (3)
By construction, Y is a positive (semi)definite matrix
formed from the sum of outer products of the individual
excitation vectors. We now seek to find
maximize tr QYð Þ
subject to tr SiYð Þ  ci
Y  0 Y is psdð Þ
(4)
where ci are the SAR constraints to be observed.
This problem has a well-understood structure, appearing
in the semidefinite relaxation approximation of quadratic
form maximization [50], and can be solved via commonly
available approaches such as the MATLAB-based modeling
system for convex optimization (CVX [52]) using different
constraints. The actual excitation vectors can be recovered
from Y using its Eigen decomposition. The phase and ampli-
tude settings are determined from the product of the Eigen
vector and the square root of its Eigen value. Time multiplex-
ing [53] is used when providing a better outcome, which is
automatically determined by the algorithm.
First, the optimization goal was set to maximize total
power absorption in the TV:
maximize tr QYð Þ
subject to tr ViYð Þ  ci
tr PYð Þ  Pmax
(5)
where tr is the trace of matrix; Y is the solution matrix (psd);
Q is the tumor-SAR matrix; Vi is the SAR matrices of the gen-
eralized VOPs; Pmax is the power limit chosen for the opti-
mization. Constraints to be defined are SAR10g,max (healthy
tissue), the total power delivered to the healthy part of the
head PHead (i.e., the remaining part of the head after numer-
ically removing the TV so that the optimization does not
limit itself) and the total available forward power PForward.
Head power deposition was constrained via the global SAR
matrix P. The possibility to limit Pmax is implemented in this
approach but so far this has itself been the subject of investi-
gations. Pmax was set so that SARLim would be the limiting
factor in all cases. For further considerations one has to bear
in mind that PHead is subject to varying absolute limits since
the mass of the remaining exposed healthy tissue depends
on patient anatomy and size of the TV. This optimization
procedure will be further referred to as the ‘power
optimization’.
The power optimization maximizes the total power deliv-
ered to the TV but does not consider the distribution of the
power deposition inside the TV. Especially in large TVs, this
could lead to a local SAR maximum while other regions of
the TV experience low RF exposure. To address this short-
coming, a second optimization algorithm was implemented
which homogenizes the power distribution within the TV by
minimizing the deviation of every local SAR10g(TV) value
from a given target SAR [50]. High target values favor the
maximization of the power deposition while lower values
favor its flatness:
minimize s
subject to s  tr QiYð Þb  s
tr ViYð Þ  ci
tr PYð Þ  Pmax
(6)
where s is the optimization goal to minimize the deviation
between each local SAR10g value and b; b>0 is the targeted
SAR10g(TV): to ensure that the algorithm targets voxels with
low exposure that need increasing rather than voxels with
high exposure that need reducing, we chose a high target
SAR of b¼ 100 W/kg as previously reported in [54];
Y¼ solution matrix (psd); Qi¼ random subsample of the SAR
matrices in the target region to reduce computational bur-
den, considering that spatially dense sampling is not
required. We used an undersampling factor of 0.5 resulting
in about 20 matrices per cm3; Vi¼ SAR matrices of the gen-
eralized VOPs and P¼global SAR matrix. Constraints that
can be defined are maximum SAR10g in the healthy tissue
SAR10g,max(healthy), the total power delivered to the healthy
part of the head PHead and the targeted SAR10g in the TV b.
This optimization procedure will be further referred to as the
‘uniformity optimization’.
To define a safe limit for SAR10g,max, we simplified
the Pennes’ bioheat transfer equation [55], setting both the
time-dependent and the conductive term to zero. Under the
assumption of a basal brain perfusion of 50ml/100 g/min, an
average SAR of 50 W/kg results in a temperature increase of
DTþ1.5 K without taking the protective response of
thermoregulatory perfusion increase into account [12]. Based
on this estimation, we chose the SAR10g,max(healthy)¼
SARlim¼ 40 W/kg for our optimizations.
For the small tumor, only the tumor volume was chosen
as TV for optimization. For the large tumor model, the TV
was defined along the clinical target volume (CTV) used for
radiation therapy according to the current guidelines of the
Radiation Therapy Oncology Group (RTOG, https://www.rtog.
org), i.e., comprising the macroscopic tumor growth, an iso-
tropic margin of 2 cm to cover potentially infiltrated brain tis-
sue plus further edematous areas. All other tissues were
considered healthy tissue and subject to the stringent con-
straint of a maximum allowed power deposition.
HTP quality assessment
Quantitative assessment of SAR-based HTP quality offers a
broad range of suggested metrics [56], each with their own
merits and drawbacks, and is still of interest to define most
promising surrogates for the resulting temperature distribu-
tion [57]. We assessed the following commonly [21,58,59]
used metrics:
i. SAR amplification factor (SAF)
SAF ¼ SAR10g,mean TVð Þ=SAR10g,mean healthyð Þ (7)
which quantifies the ratio between the average power
deposition in the TV vs. the healthy tissue but neglects
local maxima and lacks information on the efficiency of
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treatment due to missing absolute power depos-
ition levels
ii. TC25%
The target coverage (TC) with 25% of the maximum
SAR10g (TC25%) is a measure for the SAR coverage of the
TV while taking the exposure of the healthy tissue into
account, but neglects the absolute SAR10g values
reached. It is quantified as the fraction of voxels in the
TV exhibiting a local SAR10g larger than 25% of the max-
imum exposure value found in the TV, SAR10g,max(TV).
iii. Hotspot to target SAR quotient (HTQ)
HTQ ¼ P1,mean SAR10g healthyð Þ
 
=SAR10g,mean TVð Þ (8)
which focuses more on formation of local maxima than
the SAF by comparing average SAR10g values in the first
percentile (P1) of healthy voxels exposed to the highest
SAR10g with the average SAR10g in the TV, but again
neglects the absolute values reached.
In addition, to address some shortcomings of these met-
rics, we propose:
iv. Performance indicator (PI)
PI ðW=kgÞ ¼ SAR10g,maxðTVÞ  SAF  TCSAR>Lim (9)
a combined measure addressing the shortcomings of
the above metrics. While SAR10g,max(TV) reflects the
absolute power deposition, SAF is a measure of how
well healthy tissue is spared. Whether the exposure in
the TV is focused to a small volume reaching high peak
SAR10g,max(TV) values or exhibits a homogeneous power
deposition in the TV is addressed by quantifying the
fraction of voxels in the TV (TC) where exposure levels
are higher than those allowed in the healthy tissue,
TCSAR>Lim. We expect this last metric to be of major
interest when comparing the two optimiza-
tion algorithms.
A schematic overview of all metrics is summarized in
Figure 2.
MR imaging evaluation
To demonstrate that the RF applicators are also suitable
for MRI and MRTh, magnetic transmission field (B1
þ) maps
were calculated. A magnitude least square phase and
amplitude B1
þ shimming [60] was performed in MATLAB
for an ellipsoidal region of interest covering the brain by
using the dimensions of a bounding box around the brain
to define the axes of the ellipsoid. The imaging perform-
ance of each design was evaluated based on the transmit
efficiency Bþ1 =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SAR10g,max
p
and transmit uniformity across
the ellipsoidal region of interest (coefficient of vari-
ation, COV).
Results
Radiofrequency antenna arrays
For both head models, the reflection coefficients for all con-
figurations are below –32 dB. Among all designs, the
coupling coefficients for Design 1 (SmallTumorModel) are the
highest with –12.8 dB. For the building blocks with the high
dielectric permittivity (Er¼200), all arrays could be perfectly
matched and tuned to Sii<Sij<–17.8 dB. Such ceramic slurry
can be produced using a mixture of BaTiO3 and CaTiO3 pow-
der immersed in D2O [27]. The highest scattering parameters
for all designs are given in Table 2 (full matrices are provided
in the Supplementary Figure 1.2).
Small tumor model
The power optimization algorithm yielded an increased RF
power deposition with a TC25% of 100% in the small TV for
all configurations. For Designs 1, 5, 6 and 7, the cumulative
exposure of two excitation settings (phase and amplitude)
yields the optimized SAR10g distribution. The solution for all
other designs consists of one excitation vector. The max-
imum intensity projections (MIPs) for the obtained SAR10g
distributions overlaid with the SAR50 and SAR90 iso-contours
are shown in the center column of Figure 3. Additionally, the
SAR10g maps in three orthogonal slices positioned in the cen-
ter of the TV are shown in the center column of
Supplementary Figure 3.2. The metrics are visualized in the
top left of Figure 4 while all values are listed in Table 2.
Increasing the number of channels from 8 to 16 when
moving from Design 1 to Design 2 showed an increase in RF
power deposition in the TV (PTumor(Design 2)¼1.6W vs.
PTumor(Design 1)¼1.5W) – but also in the healthy part of the
brain. Moving to Design 3 and introducing the third focusing
dimension significantly decreased the exposure of the
healthy tissue (SARmean(healthy, Design 3)¼11.8W/kg vs.
SARmean(healthy, Design 2)¼14.6W/kg). Arranging the anten-
nae in the elliptical manner (Design 4) allowed for higher
total incident power (PHead(Design 4)¼77.0W vs. PHead
(Design 3)¼70.9W) before reaching the local SAR10g (healthy)
limit, yielding a performance indicator of PI ¼ 88W/kg,
according to Equation (9). The HTQ as defined in Equation
(8) decreases from HTQ (Design 1)¼1.00 to HTQ (Design
4)¼0.79 with these design improvements. Increasing the lon-
gitudinal coverage of the head (Design 5) enabled further
focusing of the RF waves to the TV (PI ¼ 178W/kg).
Changing to the elliptical setup of Design 6 decreased the PI
(PI(Design 6)¼ 152W/kg). Adding more degrees of freedom
by increasing the number of channels to 32 further increased
the PI for the circular but not for the elliptical arrangement
(PI(Design 7)¼191W/kg, PI(Design 8)¼ 116W/kg). Again, the
HTQ values support these findings. The introduction of the
water bolus allowed for a significant reduction of surface
SAR10g. As a result, Designs 9 and 10 are the only designs
where the limiting SAR10,max¼ 40W/kg was reached adjacent
to the TV rather than at the surface. In combination with
a significant decrease in exposure of healthy tissue
(PHead(Design 9)¼ 38.5W vs. PHead(Design 3)¼ 70.9W and
PHead(Design 10)¼ 36.6W vs. PHead(Design 4)¼ 77.0W), this
resulted in significantly better performance for both arrays
with water bolus (PI(Design 9)¼ 244W/kg, PI(Design 10)¼
277W/kg). The HTQ values are among the lowest
(HTQ(Design 9)¼ 0.83, HTQ(Design 10)¼0.82) but
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Figure 3. Top row: sagittal, coronal and axial section through the small tumor model. Left: description and front view of each design simulated together with the
small tumor model; maximum intensity projection of the SAR10g distribution after hyperthermia treatment planning for the power optimization (center) and the
uniformity optimization (right).
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outperformed by Design 7. Overall, the differences in HTQ
for all 10 designs are very low, except for Design 1, showing
the highest HTQ (HTQ(Design 1)¼1.00).
The uniformity optimization yielded a superposition of two
excitation phase and amplitude settings for all arrays without
a water bolus (Designs 1–8), where one setting was found
sufficient. The MIPs for the obtained SAR10g distributions
overlaid with the SAR50 and SAR90 iso-contours are shown in
the right column of Figure 3. Additionally, the SAR10g maps
in three orthogonal slices positioned in the center of the TV
are shown in the right column of Supplementary Figure 3.2.
The metrics are visualized in the top right of Figure 4 while
all values are listed in Table 2. An increased TCSAR>Lim of the
TV was achieved for Designs 2, 3 and 5 when compared to
the power optimization. However, in all cases, the improve-
ment comes at the expense of a decrease in SAF, as defined
in Equation (7), and maximum SAR10g in the TV. The TC25%
of 100% could be maintained for all configurations. The HTQ
values show the same behavior throughout the design itera-
tions but exhibit a minor increase overall (lowest:
HTQ(Design 4)¼0.82, highest: HTQ(Design 1)¼1.04). As a con-
sequence, employing the uniformity optimization with the
small tumor model showed no significant PI improvement.
Large tumor volume
The more frontal location of the large TV (V¼ 500ml)
resulted in a higher power deposition in the entire brain and
including the region of the eyes and the nose. The MIPs for
the obtained SAR10g distributions overlaid with the SAR50
and SAR90 iso-contours are shown in Figure 5. Additionally,
the SAR10g maps in three orthogonal slices positioned in the
center of the TV are shown in the Supplementary Figure 5.2.
Figure 4. Qualitative comparison of the metrics used to assess HTP quality. The top row displays the results obtained for the small tumor model; the bottom row
shows the results for the large tumor model. The results in the left column are obtained using the power optimization; the results of the uniformity optimization
are in the right column. Blue lines highlight designs 9 and 10 equipped with a water bolus. All values are normalized to their respective intra-design, intra-opti-
mizer maximum. Metrics labeled with a green font combine to the performance indicator. For better visualization so that higher values are always better, we plot-
ted the reciprocal of the HTQ (1/HTQ¼ THQ). For the small tumor model, adding the water bolus clearly improved the SAF and pushed toward the highest values
for SARmax(TV) and VSAR>Lim. For the large tumor model, the results are very heterogeneous; the water bolus does not add a clear improvement.
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Figure 5. Top row: sagittal, coronal and axial section through the large tumor model. Left: description and front view of each design simulated together with the
large tumor model; maximum intensity projection of the SAR10g distribution after hyperthermia treatment planning for the power optimization (center) and the
uniformity optimization (right).
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The metrics are visualized in the bottom row of Figure 4
while all values are listed in Table 2.
The power optimization yielded a superposition of two
excitation phase and amplitude settings for Designs 1, 2, 3, 7
and 8. The TC25% was well above 75% for all configurations
(84–100%) without the water bolus. Significant differences
were observed for TV coverage by using a higher amount of
channels. At the same time, a reduction in exposure of
healthy tissue was achieved. The PI increased with every iter-
ation of the antenna array up to Design 6 (PImin¼21W/kg,
PImax¼210W/kg), which also exhibits the best HTQ value
(HTQ(Design 6)¼0.79). This level of exposure could not be
maintained when moving to Design 7, due to the high dens-
ity of transmit elements close to the nose, resulting in the
formation of a local SAR maximum (PI(Design 7)¼82W/kg,
HTQ ¼ 0.87). This could partly be countered with the ellip-
tical arrangement in Design 8 (PI(Design 8)¼131W/kg,
HTQ(Design 8)¼0.84). The inclusion of a water bolus in
Designs 9 and 10 did not show the same improvement as
for the small TV. While an increase in SARmax(TV) and SAF
could be observed, the enhanced RF focusing led to a signifi-
cant decrease in TCSAR>Lim and TC25% (PI(Design 9)¼105W/
kg vs. PI(Design 3)¼117W/kg, HTQ(Design(9)¼0.99 vs.
HTQ(Design 3)¼0.86, TC25%(Design 9)¼76% vs. TC25%(Design
3)¼93%). Improvements were observed by moving to
the elliptical Design 10 (PI(Design 10)¼141W/kg,
HTQ(Design(10)¼0.91, TC25%(Design 10)¼93%), but the
results did not match Design 6.
The uniformity optimization was designed to improve the
HTP for large TVs by spreading the power deposition in the
TV. This was achieved by a superposition of two excitation
settings for all arrays but Design 10, where a third setting
contributed another 8% to the total delivered power. In all
non-bolus designs, the second phase setting contributed as
much as 16–40% to the total delivered power vs. 0–31% in
the power optimization.
The modest performance achieved with the in-plane
arrays of Designs 1 and 2 was substantially enhanced when
increasing the longitudinal coverage (PI(Design 5)¼99W/kg,
PI(Design 3)¼93W/kg, PI(Design 2)¼26W/kg; HTQ(Design
5)¼0.88, HTQ(Design 3)¼0.92, HTQ(Design 2)¼1.28). The add-
itional degree of freedom of 32 channels in Design 7 did not
add to the improvement but rather boosted the formation of
a local SAR maximum (PI(Design 7)¼47W/kg, HTQ(Design
7)¼0.98). All elliptical configurations outperformed the circu-
lar counterparts in PI (PI(Design 4)¼95W/kg vs. PI(Design
3)¼93, HTQ(Design 4)¼0.91 vs. HTQ(Design 3)¼0.92;
PI(Design 6)¼128W/kg vs. PI(Design 5)¼99W/kg, HTQ(Design
6)¼0.85 vs. HTQ(Design 5)¼0.88; PI(Design 8)¼131W/kg vs.
PI(Design 7)¼47W/kg, HTQ(Design 8)¼0.89 vs. HTQ(Design
7)¼0.98). Minor improvements in SAF and as a result in PI
were found when increasing the number of channels from
16 to 32 in the elliptical arrangement (PI(Design 8)¼131W/
kg vs. PI(Design 6)¼128W/kg). Adding the water bolus sig-
nificantly decreased the PI results for Design 9 (PI(Design
9)¼63W/kg vs. PI(Design 3)¼17W/kg) due to overfocusing
(TCSAR>Lim(Design 9)¼29.7% vs. TCSAR>Lim(Design 3)¼47.5%),
despite an increase in maximum power deposition
(SARmax(TV,Design 9)¼101.1W/kg vs. SARmax(TV,Design
3)¼82.43W/kg) with poorer results for HTQ and TC25%
(HTQ(Design 9)¼1.02 vs. HTQ(Design 3)¼0.92, TC25%(Design
9¼ 80% vs. TC25%(Design 3)¼100%). For Design 10, no
improvement could be found (PI(Design 10)¼63W/kg,
HTQ(Design 10)¼1.06, TC25%(Design 10)¼100%). Using the
uniformity optimization helped TC25% values reach 100% for
all arrays except Design 9, where only 80% could be reached,
stating a significant improvement over the power
optimization.
MR imaging evaluation
For the small tumor model, the best B1
þ transmit efficiency
was obtained for Design 1 (Bþ1 =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SAR10g,max
p ðDesign 1Þ ¼
0:25lT=
ffiffiffiffiffiffiffiffiffiffiffiffiffi
W  kgp 621:7%), which was comparable to Design
2ðBþ1 =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SAR10g,max
p ðDesign 2Þ ¼ 0:21lT= ffiffiffiffiffiffiffiffiffiffiffiffiffiW  kgp 619:2%). The
transmit efficiency was lowest for Design 7
ðBþ1 =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SAR10g,max
p ðDesign 7Þ ¼ 0:02lT= ffiffiffiffiffiffiffiffiffiffiffiffiffiW  kgp ) although the
homogeneity improved (COV(Design 7)¼11.0%).
For the large tumor model, all designs except Design
1 ðBþ1 =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SAR10g,max
p
Design 1ð Þ ¼ 0:59lT=
ffiffiffiffiffiffiffiffiffiffiffiffiffi
W  kgp 628:1%)
showed lower or similar B1
þ transmit efficiencies compared
to the small tumor model. Design 8 showed the lowest B1
þ
transmit efficiency (Bþ1 =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SAR10g,max
p
Design 8ð Þ ¼ 0:04lT=ffiffiffiffiffiffiffiffiffiffiffiffiffi
W  kgp , COV(Design 8)¼14.8%). A synopsis of the transmit
efficiency and transmit uniformity is provided in the right
column of Table 2.
Discussion
This work examined the applicability of high density annular-
phased-array RF applicators and HTP in a small (<k/2,
Vtarget¼33.5ml) and large (>k/2, Vtarget¼500ml) TV in the
brain using EMF simulations.
Regarding the metrics used to examine our HTP quality,
we found TC25% to be least informative, reaching 100% in 33
out of 40 HTP results, even in cases where SAR10g distribu-
tion did not appear promising for treatment. The validity of
our proposed PI is supported by its correlation with the well-
established HTQ. We believe that the PI adds to the HTP
quality assessment since it offers a measure for absolute SAR
and a higher differentiation compared to the HTQ. This being
said, this work is, to the best of our knowledge, the first to
present an HTQ <1 for HTP in the head [61].
For the small tumor model, the power optimization clearly
outperformed the uniformity optimization. The TV diameter
of 4 cm approximates a third of the wavelength in tissue at
297MHz and thus stresses the physical limits of RF focusing,
thereby leading to good TC. Adding the uniformity as an
optimization criterion limits maximization of delivered RF
power. In conclusion, HTP for small TVs should be preferably
performed using the power optimization. When lifting the
SAR10g,max constraint of healthy tissue, this optimization con-
verges to an optimization of the SAF [21].
An incremental improvement in HTP performance was
accomplished when moving from Design 1 to Design 5.
Enabling the longitudinal steering in Design 3 resulted in
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increased sparing of healthy tissue. The elliptical arrange-
ment of Design 4 afforded enhanced control over superficial
power deposition. Without the use of a water bolus, the best
RF focusing was achieved by using the highest degree of
freedom for the 32 elements in Design 7. Design 8 could not
maintain this performance due to higher power deposition
in the temporal regions of the head.
Employing the uniformity optimization for the large TV
resulted in a higher coverage TCSAR>Lim for only Designs 3
and 4. Further expenses at the cost of SARmax and SAF do
not justify the use of the uniformity optimization, even
though its principal effectiveness was shown by the higher
contribution of secondary excitation settings and higher
TC25% values.
Given the large geometrical extent of the TV in the large
tumor model, the increased longitudinal coverage was essen-
tial to obtain good HTP results, peaking in the results found
for the power optimization for Design 6. All elliptical arrange-
ments allowed for better results than their circular counter-
parts. Increasing the number of elements from 16 to 32
added no clear improvement. Only TC25%(Design 8) in the
power optimization and SAF and TCSAR>Lim(Design 8) in the
uniformity optimization could be improved. All other metrics
show no improvement, even a poorer performance, upon
increasing the channel count.
Adding the water bolus supported an improvement in cou-
pling of the RF energy to the body as well as focusing for the
small tumor model. For the large tumor model, the increased
focusing lead to a decreased TV coverage in Design 9. Moving
to the elliptical Design 10 counters for some of this behavior
but does not outperform the arrays without a water bolus.
These designs show encouraging HTP results, whereby high
enough power deposition in the TV may be reached without
the requirement of a water bolus as coupling medium. This
would substantially benefit patient comfort.
From an engineering perspective, our results suggest that
it is possible to limit the RF applicator to 16 building blocks
for both tumor models. This simplifies the RF applicator
setup. Such a setup would be compatible with state-of-the-
art 7.0 T MR instruments offering up to 16 RF amplifiers
(Pmax¼2 kW) for parallel transmission. In addition, the low
coupling coefficients suggest that the copper shields might
become obsolete, which would relax engineering and manu-
facturing constraints.
To summarize, our results revealed that the 16 element
interleaved array using an elliptical arrangement provided
the best results for the small tumor model, while the 16
element elliptical two row arrangement showed the best
results for the large tumor model. This supports the idea of a
‘sliding applicator’, where the two rows of RF antennae can
be displaced with respect to each other, adapting the longi-
tudinal coverage of the brain individually in response to the
size of the TV. Since our findings support the use of a water
bolus for the small TV but not for the large TV, the question
as to whether the engineering effort of designing an adapt-
able water bolus for such an applicator is weighed by the
benefit will need to be answered by the ongoing investiga-
tion into a higher number of realistic tumor models. The
elimination of the copper shields would ease the realization
of this applicator.
To conclude, this work adds to the literature by examin-
ing integrated RF applicator concepts for thermal interven-
tions in the brain including treatment planning based on
realistic patient models. Swift translation of the RF applicator
designs examined with numerical simulations into experi-
mental prototypes remains conceptually appealing and an
ambitious undertaking en route to clinical feasibility studies
of thermal interventions of GBM.
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